Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodium

von Konovalova, Irina S., Kovalenko, Sergiy M., Kravchenko, Dmitry V., Chuev, Vladimir P.
Veröffentlicht in Acta Crystallogr E Crystallogr Commun (2021)

(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-tri­methyl­cyclo­pentane-1-carb­oxy­lic acid as a new anti-diabetic active pharmaceutical ingredient

von Kovalenko, Sergiy M., Konovalova, Irina S., Merzlikin, Sergiy I., Chuev, Vladimir P., Kravchenko, Dmitry V.
Veröffentlicht in Acta Crystallogr E Crystallogr Commun (2020)

Crystal structure, Hirshfeld analysis and a mol­ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa­diazo...

von Ivachtchenko, Alexandre V., Kovalenko, Sergiy M., Kravchenko, Dmitry V., Mitkin, Oleg D., Ivanov, Vladimir V., Langer, Thierry
Veröffentlicht in Acta Crystallogr E Crystallogr Commun (2020)

Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophe...

von Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kravchenko, Dmitry V., Kovalenko, Sergiy M., Shishkina, Svitlana V., Bunyatyan, Natalya D., Konovalova, Irina S., Dmitrieva, Irina G., Ivanov, Vladimir V., Langer, Thierry
Veröffentlicht in Heliyon (2019)

Methylation of Methyl 4-Hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate: Synthetic, Crystallographic, and Molecular Docking Studies

von Kovalenko, Sergiy M., Drushlyak, Oleksandr G., Shishkina, Svitlana V., Konovalova, Irina S., Mariutsa, Illia O., Bunyatyan, Natalya D., Kravchenko, Dmitry V., Ivanov, Vladimir V., Ivachtchenko, Alexandre V., Langer, Thierry
Veröffentlicht in Molecules (2020)

Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment

von Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kudan, Elizaveta V., Rjahovsky, Alexey A., Vorobiev, Anton A., Trifelenkov, Andrey S., Shevkun, Natalia A., Proskurina, Oxana V., Kravchenko, Dmitry V., Karapetian, Ruben N.
Veröffentlicht 2014

Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir

von Ivashchenko, Andrei A, Mitkin, Oleg D, Jones, Jeremy C, Nikitin, Alexander V, Koryakova, Angela G, Karapetian, Ruben N, Kravchenko, Dmitry V, Mochalov, Stephan V, Ryakhovskiy, Alexey A, Aladinskiy, Vladimir, Leneva, Irina A, Falynskova, Irina N, Glubokova, Ekaterina A, Govorkova, Elena A, Ivachtchenko, Alexandre V
Veröffentlicht in J Antimicrob Chemother (2020)

Effect of Aprotinin and Avifavir(®) Combination Therapy for Moderate COVID-19 Patients

von Ivashchenko, Andrey A., Azarova, Valeria N., Egorova, Alina N., Karapetian, Ruben N., Kravchenko, Dmitry V., Krivonos, Natalia V., Loginov, Vladimir G., Poyarkov, Stanislav V., Merkulova, Elena A., Rosinkova, Olga S., Savchuk, Nikolay P., Topr, Mikhail A., Simakina, Elena N., Yakubova, Elena V., Ivachtchenko, Alexandre V.
Veröffentlicht in Viruses (2021)

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

von Ivashchenko, Andrey A, Dmitriev, Kirill A, Vostokova, Natalia V, Azarova, Valeria N, Blinow, Andrew A, Egorova, Alina N, Gordeev, Ivan G, Ilin, Alexey P, Karapetian, Ruben N, Kravchenko, Dmitry V, Lomakin, Nikita V, Merkulova, Elena A, Papazova, Natalia A, Pavlikova, Elena P, Savchuk, Nikolay P, Simakina, Elena N, Sitdekov, Tagir A, Smolyarchuk, Elena A, Tikhomolova, Elena G, Yakubova, Elena V, Ivachtchenko, Alexandre V
Veröffentlicht in Clin Infect Dis (2020)